Gilead Ticks Lower On Earnings Miss

by Javier Hasse, Benzinga Editor

November 1, 2016 4:18 PM | 20 seconds read | Make a Comment

Gilead Sciences, Inc. GILD reports Q3 EPS of $2.75, missing the Street’s consensus by $0.11.
Revenue of $7.5 billion, down 9.5 percent year-over-year, managed to beat estimates by $50 million.
Full year net product sales guidance of $29.5 billion to $30.5 billion was reiterated.
Shares were trading down 1.4 percent to $73.25 after hours.

Posted In: Earnings News Guidance After-Hours Center Movers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.